http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4719208-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4155c237ba921600e5d9125cf2f6a2d |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 |
filingDate | 1986-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 1988-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3bc690127240ddf33d5b9434a1c954e3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9bad43f78aa1b93b94e4ad334a31bfa8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_05fa397243aab6a1b3520fc4a9d269c1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_738dd44de06623ee2570aa963cacfcf4 |
publicationDate | 1988-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-4719208-A |
titleOfInvention | 1,2,3,4,5,6-hexahydroazepino(4,5-B)indole derivatives, their preparation, intermediate compounds, and their application in therapeutics |
abstract | The invention is related to new 1,2,3,4,5,6-hexahydro-5-hydroyalkylazepino[4,5-b]-indole derivatives, of formula: ##STR1## in which R 1 denotes a hydrogen atom, an alkyl radical, an alkenyl radical, a benzyl radical, an alkylamino radical of the type ##STR2## where the groups R' are either hydrogen atoms or alkyl radicals or form, together with the nitrogen atom to which they are attached, a heterocyclic nucleus of the morpholinyl, piperidinyl, pyrrolidinyl or piperazinyl type, and m is 2 or 3, n R 2 denotes a hydrogen atom or a benzoyl or acyl radical, n R 3 denotes a hydrogen atom or an alkyl or benzyl radical, n R 4 denotes a hydrogen or halogen atom, an alkyl radical an alkoxy radical or a trifluoromethyl radical, and n n is 1 or 2, and the salts of addition to pharmaceutically acceptable acids, n and to process for their preparation, to intermediates obtained and to their therapeutical use in treating mental disorders. |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004023947-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7485634-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2003243328-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2003243328-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005054634-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7595311-B2 |
priorityDate | 1985-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 250.